To include your compound in the COVID-19 Resource Center, submit it here.

NEA leads Xoc's $30M series A

CNS disease company Xoc Pharmaceuticals Inc. (Los Gatos, Calif.) closed a tranched

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE